✦ LIBER ✦

Effects of angiotensin-converting enzyme inhibitors (ACEi) on zinc metabolism in patients with heart failure

✍ Scribed by Elena Trasobares; Arturo Corbatón; Montserrat González-Estecha; Jose Luis Lopez-Colón; Pilar Prats; Pilar Olivan; Jose Antonio Sánchez; Manuel Arroyo

Book ID: 108196798
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 129 KB
Volume: 21
Category: Article
ISSN: 0946-672X
DOI: 10.1016/j.jtemb.2007.09.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with angiotensin converting en

Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure

✍ Ragnar Watz; Ann-Britt Ekstrand; Victoria Engelbrektson; Björn Beermann 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 284 KB

Therapeutic implications of escape from

Therapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure

✍ Pierre Vladimir Ennezat; Michael Berlowitz; Edmund H. Sonnenblick; Thierry H. Le 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 175 KB

Dose-finding study of imidapril, a novel

Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure

✍ Y. M. Pinto; D. J. van Veldhuisen; R. T. Tjon-Ka-Jie; G. Rooks; T. Netzer; K. I. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 214 KB

Metabolic effects of long-term angiotens

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements

Effects of a new angiotensin-converting

Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure

✍ T. Kinugawa; M. Kato; M. Mori; A. Endo; T. Kato; T. Hamada; N. Noguchi; H. Omoda 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 301 KB

Effects of treatment with angiotensin-co

Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats

✍ Masatoshi Yamamoto; Mitsumine Fukui; Ichiyu Shou; Li Ning Wang; Keiko Sekizuka; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

The aim of this study was to determine if treatment with angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor antagonists (AIIRA) might decrease urinary albumin excretion and prevent glomerular enlargement and glomerulosclerosis in subtotal (5/6) nephrectomized rats. Morphometr